Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Other Accumulated Expenses (2016 - 2021)

Marimed (MRMD) has disclosed Other Accumulated Expenses for 8 consecutive years, with $2000.0 as the latest value for Q4 2021.

  • On a quarterly basis, Other Accumulated Expenses fell 91.54% to $2000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was $2000.0, a 91.54% decrease, with the full-year FY2021 number at $2000.0, down 91.54% from a year prior.
  • Other Accumulated Expenses was $2000.0 for Q4 2021 at Marimed, down from $23640.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.6 million in Q1 2020 to a low of $2000.0 in Q4 2021.
  • A 4-year average of $713560.1 and a median of $541588.0 in 2017 define the central range for Other Accumulated Expenses.
  • Biggest YoY gain for Other Accumulated Expenses was 660.32% in 2020; the steepest drop was 97.25% in 2020.
  • Marimed's Other Accumulated Expenses stood at $225000.0 in 2017, then soared by 281.41% to $858176.0 in 2019, then crashed by 97.25% to $23640.0 in 2020, then crashed by 91.54% to $2000.0 in 2021.
  • Per Business Quant, the three most recent readings for MRMD's Other Accumulated Expenses are $2000.0 (Q4 2021), $23640.0 (Q4 2020), and $1.5 million (Q3 2020).